Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03EOK
|
||||
| Former ID |
DNC012490
|
||||
| Drug Name |
N-Indan-1-yl-2-(1H-indol-3-yl)-2-oxo-acetamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526094] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H16N2O2
|
||||
| Canonical SMILES |
C1CC2=CC=CC=C2C1NC(=O)C(=O)C3=CNC4=CC=CC=C43
|
||||
| InChI |
1S/C19H16N2O2/c22-18(15-11-20-16-8-4-3-7-14(15)16)19(23)21-17-10-9-12-5-1-2-6-13(12)17/h1-8,11,17,20H,9-10H2,(H,21,23)
|
||||
| InChIKey |
HPOOEGNMALNZJV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [526094] | |
| Gamma-aminobutyric acid receptor | Target Info | Inhibitor | [526094] | ||
| Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [526094] | ||
| Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [526094] | ||
| WikiPathways | Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
| Iron uptake and transportWP2754:Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
| Iron uptake and transportWP706:SIDS Susceptibility Pathways | |||||
| Iron uptake and transport | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.